ResQ132EX

Recombinant Bacillus Calmette-Guérin · ImmunityBio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ResQ132EX, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer